Journal profile · HEMATOLOGY
Journal of Blood Medicine
ISSN 1179-2736 · Dove Medical Press · United Kingdom
Journal of Blood Medicine: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.2 (journal website); fully open access; APC about USD 3,940; median 119 days to acceptance (100 articles, last 24 months); acceptance rate 43% (journal website); 52 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Journal of Blood Medicine is published by Dove Medical Press and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Hemoglobinopathies and Related Disorders, Blood groups and transfusion and Iron Metabolism and Disorders, together about 25% of its articles. Its main subfields are Hematology. (generated from OpenAlex topic counts and CAS ranking data)
Editor-in-Chief: Martin Bluth, MD, PhD The Journal of Blood Medicine is an international, peer-reviewed, open access, online journal publishing laboratory, experimental and clinical aspects of all topics pertaining to blood-based medicine including but not limited to: Transfusion Medicine (blood components, stem cell transplantation, apheresis, gene-based therapeutics) Blood collection, Donor issues, Transmittable diseases, and Blood banking logistics Immunohematology Artificial and alternative blood-based therapeutics Hematology including disorders/pathology related to leukocytes/immunology, red cells, platelets and hemostasis Biotechnology/nanotechnology of blood related medicine Legal aspects of blood medicine Historical perspectives Original research, short reports, reviews, case reports and commentaries are invited. The Journal of Blood Medicine will no longer consider meta-analyses for publication. Updated 6 August 2025
From the journal's Aims & Scope
Research area (LetPub): HEMATOLOGY
Editor-in-chief Martin BluthPublisher website
Editorial board by country: none in mainland China; most named United States 13, Italy 5, Japan 2, Egypt 2 (22 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Hemoglobinopathies and Related DisordersMedicine8.6%
- Blood groups and transfusionMedicine8.4%
- Iron Metabolism and DisordersMedicine8.1%
- Platelet Disorders and TreatmentsMedicine7.6%
- Hemophilia Treatment and ResearchMedicine7.5%
- Blood transfusion and managementMedicine7%
- Blood donation and transfusion practicesBusiness, Management and Accounting6.1%
- Venous Thromboembolism Diagnosis and ManagementMedicine3.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Hematology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
JCR / CiteScore quartiles on the journal's website
- CiteScore Q2 · 2025
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
SJR, CiteScore, Impact FactorPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 2.2Publisher website ·
- 5-year impact factor (publisher)
- 4.4Publisher website ·
- CiteScore 2026-06
- 4.4LetPub ·
- CiteScore (publisher) 2025
- 1.27Publisher website ·
- SJR 2026-06
- 0.71LetPub ·
- SNIP 2026-06
- 1.27LetPub ·
- h-index
- 56OpenAlex ·
- i10-index
- 329OpenAlex ·
- 2-year mean citedness
- 1.7OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 98.83%LetPub ·
Volume
- Articles per year
- 53LetPub ·
- Downloads per year (publisher)
- 141,347Publisher website ·
Articles by year OpenAlex count · 752 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 57 | 57 | 9 |
| 2025 | 52 | 52 | 94 |
| 2024 | 53 | 53 | 173 |
| 2023 | 66 | 66 | 688 |
| 2022 | 77 | 77 | 1,013 |
| 2021 | 107 | 107 | 1,495 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
119 daysMedian, submission to acceptance · P25–P75 92 days – 157 days
- Acceptance to online
- median 15 days (100 articles)
- Submission to online
- median 140 days
- Sample
- 100 articles with submission and acceptance dates (122 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 16 weeksLetPub ·
- Acceptance rate (publisher)
- 43%Publisher website ·
- Desk decision
- 46 daysPublisher website ·
- Submission to publication (journal-reported)
- about 16 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 3,940 | Yes | CC BY, CC BY-NC | |
| OpenAlex | USD 2,320 | — | — | |
| LetPub | USD 2,990 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted2
- case reportAuthors may use these detailed descriptions of different paper types accepted by Dove Medical Press (case reports, reviews, etc) to decide how to label their pa…Length not stated
- reviewAuthors may use these detailed descriptions of different paper types accepted by Dove Medical Press (case reports, reviews, etc) to decide how to label their pa…Length not stated
Policy excerpts from the journal's websitePeer review
- Peer review
Member of COPE Model summary
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Dove Medical Press
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 1179-2736
- Official links
- Journal homepage ↗DOAJ
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Journal of Blood Medicine
What CAS zone is Journal of Blood Medicine in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Blood Medicine is in Zone 4 of Medicine, and in Zone 4 of the minor category Hematology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Blood Medicine?
The journal's website gives an impact factor of 2.2 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 4.4, h-index 56.
How long does peer review take at Journal of Blood Medicine?
Based on the dates recorded on 100 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 119 days (interquartile range 92–157 days); authors report an average review time of about 16 weeks; the journal's website gives an acceptance rate of 43%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Journal of Blood Medicine based?
Of the 22 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (13), Italy (5) and Japan (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Blood Medicine?
According to LetPub and DOAJ records, Journal of Blood Medicine is indexed in ESCI, Scopus and DOAJ.
Is Journal of Blood Medicine open access, and what is the APC?
Journal of Blood Medicine is a fully open-access journal. APC about USD 3,940.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .